Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: An implication to coronary vasospasm

Journal of Cellular Physiology

Volumn 226, Issue 10, 2011, Pages 2712-2720

  Qipshidze, Natia ^a   Metreveli, Naira ^a   Lominadze, David ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CYSTATHIONINE BETA SYNTHASE; DRINKING WATER; FOLIC ACID; NITRIC OXIDE;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL THICKNESS; CANNULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY SPASM; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; HETEROZYGOTE; HYPERHOMOCYSTEINEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ACETYLCHOLINE; ANIMALS; CHOLINERGIC AGONISTS; CORONARY VASOSPASM; CORONARY VESSELS; DRUG SYNERGISM; FEMALE; FOLIC ACID; HYPERHOMOCYSTEINEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; VASOCONSTRICTION; VITAMIN B COMPLEX;

MUS;

EID: 79960660336     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22621     Document Type: Article

References (37)

1. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. 2008. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: A randomized trial. JAMA 299: 2027-2036 .
2. Antoniades C, Shirodaria C, Warrick N, Cai S, de Bono J, Lee J, Leeson P, Neubauer S, Ratnatunga C, Pillai R, Refsum H, Channon KM. 2006. 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: Effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114: 1193-1201.
3. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K. 2006. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354: 1578-1588 .
4. Boulanger CM. 1999. Secondary endothelial dysfunction: Hypertension and heart failure. J Mol Cell Cardiol 31: 39-49.
5. Crabtree MJ, Channon KM. 2009. Dihydrofolate reductase and biopterin recycling in cardiovascular disease. J Mol Cell Cardiol 47: 749-751 (editorial).
6. Crabtree MJ, Tatham AL, Hale AB, Alp NJ, Channon KM. 2009. Critical role of tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of eNOS coupling: Relative importance of the de novo biopterin synthesis versus salvage pathways. J Biol Chem 284: 28128-28136.
7. Dayal S, Lentz SR. 2008. Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol 28: 1596-11605.
8. Den Heijer M, Lewington S, Clarke R. 2005. Homocysteine, MTHFR and risk of venous thrombosis: A meta-analysis of published epidemiological studies. J Thromb Haemost 3: 292-299.
9. Doshi SN, McDowell IFW, Moat SJ, Lang D, Newcombe RG, Kredan MB, Lewis MJ, Goodfellow J. 2001. Folate improves endothelial function in coronary artery disease: An effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol 21: 1196-1202.
10. Doshi SN, McDowell IFW, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellow J. 2002. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105: 22-26.
11. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI, Yaghoubi M, Goldschmidt-Clermont PJ, Farber HW, Cohen R, Loscalzo J. 2000. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 106: 483-491.
12. Feliciano L, Henning RJ. 1999. Coronary artery blood how: Physiologic and pathophysiologic regulation. Clin Cardiol 22: 775-786.
13. Fukagawa NK, Minaker KL, Young VR, Rowe JW. 1986. Insulin dose-dependent reductions in plasma amino acids in man. Am J Physiol 250: E13-E17.
14. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. 2001. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104: 2673-2678.
15. Hyndman ME, Rosenfeld RJ, Anderson TJ, Parsons HG. 2002. Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol 282: H2167-H2172.
16. Liu Q. 1999. Constriction to hypoxia-reoxygenation in isolated mouse coronary arteries: Role of endothelium and superoxide. J Appl Physiol 87: 1392-1396.
17. Looft-Wilson RC, Ashley BS, Billing JE, Wolfert MR, Ambrecht LA, Bearden SE. 2008. Chronic diet induced hyperhomocysteinemia impairs eNOS regulaton in mouse mesenteric arteries. Am J Physiol Regul Integr Comp Physiol 295: R59-R66.
18. Ludmer PLSA, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. 1986. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315: 1046-1051.
19. Majtan T, Liu L, Carpenter JF, Kraus JP. 2010. Rescue of cystathionine β-synthase (CBS) mutants with chemical chaperones. J Biol Chem 285: 15866-15873.
20. Messika AH, Kaluski DN, Lev E, Iakobishvili Z, Shohat M, Hasdai D, Mager A. 2010. Nutrigenetic impact of daily folate intake on plasma homocysteine and folate levels in patients with different methylenetetrahydrofolate reductase genotypes. Eur J Cardiovasc Prev Rehabil 17: 701-705.
21. Muller JM, Davis MJ, Chilian WM. 1996. Integrated regulation of pressure and flow in the coronary microcirculation. Cardiovasc Res 32: 668-678.
22. Nakano EHJ, Powers HJ. 2001. Folate protects against oxidative modification of human LDL. Br J Nutr 86: 637-639.
23. Qipshidze N, Tyagi N, Sen U, Givvimani S, Metreveli N, Lominadze D, Tyagi SC. 2010. Folic acid mitigated cardiac dysfunction by normalizing the levels of tissue inhibitor of metalloproteinase and homocysteine-metabolizing enzymes postmyocardial infarction in mice. Am J Physiol Heart Circ Physiol 299: H1484-H1493.
24. Robert K, Maurin N, Vayssettes C, Siauve N, Janel N. 2005. Cystathionine beta synthase deficiency affects mouse endochondral ossification. Anat Rec A Discov Mol Cell Evol Biol 282: 1-7.
25. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, Meier B, Turi ZG, Hess OM. 2001. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345: 1593-1600.
26. Sen U, Munjal C, Qipshidze N, Abe O, Gargoum R, Tyagi SC. 2010. Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis. Am J Nephrol 31: 442-455.
27. Shimokawa H. 1999. Primary endothelial dysfunction: Atherosclerosis. J Mol Cell Cardiol 31: 23-37.
28. Steed MM, Tyagi N, Sen U, Schuschke DA, Joshua IG, Tyagi SC. 2010. Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS-/-, and iNOS-/- mice. Am J Physiol Lung Cell Mol Physiol 299: L301-L311.
29. Tiefenbacher CP, Tina MB, Vahl C, Amann K, Vogt A, Kübler W. 2000. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation 102: 2172-2179.
30. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang C-H, Stampfer M. 2004. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA 291: 565-575.
31. Tyagi SC, Smiley LM, Mujumdar VS, Clonts B, Parker JL. 1998. Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone. Mol Cell Biochem 181: 107-116.
32. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A. 2003. High pressure induces superoxide production in isolated arteries via PKC-dependent activation of NADPHoxidase. Circulation 108: 1253-1258.
33. Verhaar MC, Wever RMF, Kastelein JJP, van Dam T, Koomans HA, Rabelink TJ. 1998. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 97: 237-241.
34. Wang J, Xu XB, Wolin MS, Hintze TH. 1994. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol 226: H670-H680.
35. Westerhof N, Boer C, Lamberts RR, Sipkema P. 2006. Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev 86: 1263-1308.
36. Wilkinson IB, MacCallum H, Cockcroft JR, Webb DJ. 2002. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 53: 189-192.
37. Wilson PW. 2002. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 288: 2015-2022.